3,128 reports of this reaction
1.8% of all FINGOLIMOD HCL reports
#11 most reported adverse reaction
DRUG INEFFECTIVE is the #11 most commonly reported adverse reaction for FINGOLIMOD HCL, manufactured by Novartis Pharmaceuticals Corporation. There are 3,128 FDA adverse event reports linking FINGOLIMOD HCL to DRUG INEFFECTIVE. This represents approximately 1.8% of all 175,367 adverse event reports for this drug.
Patients taking FINGOLIMOD HCL who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is a less commonly reported adverse event for FINGOLIMOD HCL, but still significant enough to appear in the safety profile.
In addition to drug ineffective, the following adverse reactions have been reported for FINGOLIMOD HCL:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 3,128 FDA reports for FINGOLIMOD HCL. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 1.8% of all adverse event reports for FINGOLIMOD HCL, making it a notable side effect.
If you experience drug ineffective while taking FINGOLIMOD HCL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.